Thema
Journal Article
5
Novel anticoagulants
1
QS-21
1
adjuvant
1
andexanet alfa
1
apixaban
1
bleeding
1
dabigatran
1
deep venous thrombosis (DVT)
1
hemorrhagic complications
1
idarucizumab
1
prostate cancer
1
pulmonary embolism (PE)
1
rivaroxaban
1
vaccines
1
venous thromboembolism (VTE)
1
vitamin K antagonist (VKA)
1
warfarin
1